Literature DB >> 21672274

Cardiac-related impedance changes obtained by electrical impedance tomography: an acceptable parameter for assessment of pulmonary perfusion?

Gerhard Hellige, Guenter Hahn.   

Abstract

Mesh:

Year:  2011        PMID: 21672274      PMCID: PMC3218984          DOI: 10.1186/cc10231

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.

Electrical impedance tomography has become a tool for monitoring regional ventilation. Interest is growing to derive additional information on pulmonary perfusion and ventilation/perfusion distribution. Since signals recorded by electrical impedance tomography also contain cardiac-related impedance changes, attempts are made to evaluate them in view of perfusion. Recently in Critical Care a corresponding study applying an advanced filtering technique for separating cardiac signals from the dominant ventilation component was published [1]. The quality of the concept is demonstrated by comparing the results with solitary cardiac signals during breath-hold. Similar to other publications dealing with this approach, the correct term cardiac-related impedance changes is substituted by perfusion. Although major aspects of limitations and missing validation are addressed in the discussion, the key message presented is that 'it is possible to distinguish between lung ventilation and perfusion using electrical impedance tomography'. Vascular volume pulses which are the reasons for cardiac-related impedance changes in the lung area obviously do not unequivocally represent perfusion. Even peripherally occluded arteries will pulsate without flow. These pulsations are dependent on blood pressure and vascular as well as surrounding tissue compliance. A reasonable approach to assess perfusion by electrical impedance tomography is the impedance indicator dilution technique, which is clearly favoured by recent publications [2-4]. In contrast to the questionable pulsation approach, a homogeneous distribution of perfusion and ventilation/perfusion ratios was obtained [5]. In summary, the interpretation of cardiac-related impedance changes in view of perfusion will not be permissible until validation by established reference techniques including relevant pathophysiological conditions.

Competing interests

The authors declare that they have no competing interests.
  3 in total

Review 1.  Impedance tomography as a new monitoring technique.

Authors:  Thomas Muders; Henning Luepschen; Christian Putensen
Journal:  Curr Opin Crit Care       Date:  2010-06       Impact factor: 3.687

Review 2.  Electrical impedance tomography.

Authors:  Eduardo L V Costa; Raul Gonzalez Lima; Marcelo B P Amato
Journal:  Curr Opin Crit Care       Date:  2009-02       Impact factor: 3.687

3.  Measurement of ventilation and cardiac related impedance changes with electrical impedance tomography.

Authors:  Caroline A Grant; Trang Pham; Judith Hough; Thomas Riedel; Christian Stocker; Andreas Schibler
Journal:  Crit Care       Date:  2011-01-25       Impact factor: 9.097

  3 in total
  3 in total

1.  Application of internal electrodes to the oesophageal and tracheal tube in an animal trial: evaluation of its clinical and technical potentiality in electrical impedance tomography.

Authors:  Michael Czaplik; Christoph Hoog Antink; Rolf Rossaint; Steffen Leonhardt
Journal:  J Clin Monit Comput       Date:  2013-11-27       Impact factor: 2.502

2.  Noninvasive pulmonary artery pressure monitoring by EIT: a model-based feasibility study.

Authors:  Martin Proença; Fabian Braun; Josep Solà; Jean-Philippe Thiran; Mathieu Lemay
Journal:  Med Biol Eng Comput       Date:  2016-09-17       Impact factor: 2.602

3.  Electrical impedance tomography in pulmonary arterial hypertension.

Authors:  André L D Hovnanian; Eduardo L V Costa; Susana Hoette; Caio J C S Fernandes; Carlos V P Jardim; Bruno A Dias; Luciana T K Morinaga; Marcelo B P Amato; Rogério Souza
Journal:  PLoS One       Date:  2021-03-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.